IBDEI1QS ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,31179,0)
 ;;=L29.0^^190^1932^251
 ;;^UTILITY(U,$J,358.3,31179,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31179,1,3,0)
 ;;=3^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,31179,1,4,0)
 ;;=4^L29.0
 ;;^UTILITY(U,$J,358.3,31179,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,31180,0)
 ;;=L29.9^^190^1932^252
 ;;^UTILITY(U,$J,358.3,31180,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31180,1,3,0)
 ;;=3^Pruritus,Unspec
 ;;^UTILITY(U,$J,358.3,31180,1,4,0)
 ;;=4^L29.9
 ;;^UTILITY(U,$J,358.3,31180,2)
 ;;=^5009153
 ;;^UTILITY(U,$J,358.3,31181,0)
 ;;=L30.0^^190^1932^233
 ;;^UTILITY(U,$J,358.3,31181,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31181,1,3,0)
 ;;=3^Nummular Dermatitis
 ;;^UTILITY(U,$J,358.3,31181,1,4,0)
 ;;=4^L30.0
 ;;^UTILITY(U,$J,358.3,31181,2)
 ;;=^186823
 ;;^UTILITY(U,$J,358.3,31182,0)
 ;;=L30.1^^190^1932^140
 ;;^UTILITY(U,$J,358.3,31182,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31182,1,3,0)
 ;;=3^Dyshidrosis
 ;;^UTILITY(U,$J,358.3,31182,1,4,0)
 ;;=4^L30.1
 ;;^UTILITY(U,$J,358.3,31182,2)
 ;;=^5009154
 ;;^UTILITY(U,$J,358.3,31183,0)
 ;;=L30.2^^190^1932^132
 ;;^UTILITY(U,$J,358.3,31183,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31183,1,3,0)
 ;;=3^Cutaneous Autosensitization
 ;;^UTILITY(U,$J,358.3,31183,1,4,0)
 ;;=4^L30.2
 ;;^UTILITY(U,$J,358.3,31183,2)
 ;;=^5009155
 ;;^UTILITY(U,$J,358.3,31184,0)
 ;;=L30.4^^190^1932^144
 ;;^UTILITY(U,$J,358.3,31184,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31184,1,3,0)
 ;;=3^Erythema Intertrigo
 ;;^UTILITY(U,$J,358.3,31184,1,4,0)
 ;;=4^L30.4
 ;;^UTILITY(U,$J,358.3,31184,2)
 ;;=^5009157
 ;;^UTILITY(U,$J,358.3,31185,0)
 ;;=L30.8^^190^1932^135
 ;;^UTILITY(U,$J,358.3,31185,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31185,1,3,0)
 ;;=3^Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,31185,1,4,0)
 ;;=4^L30.8
 ;;^UTILITY(U,$J,358.3,31185,2)
 ;;=^5009158
 ;;^UTILITY(U,$J,358.3,31186,0)
 ;;=L30.9^^190^1932^136
 ;;^UTILITY(U,$J,358.3,31186,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31186,1,3,0)
 ;;=3^Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,31186,1,4,0)
 ;;=4^L30.9
 ;;^UTILITY(U,$J,358.3,31186,2)
 ;;=^5009159
 ;;^UTILITY(U,$J,358.3,31187,0)
 ;;=L40.0^^190^1932^254
 ;;^UTILITY(U,$J,358.3,31187,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31187,1,3,0)
 ;;=3^Psoriasis Vulgaris
 ;;^UTILITY(U,$J,358.3,31187,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,31187,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,31188,0)
 ;;=L40.1^^190^1932^257
 ;;^UTILITY(U,$J,358.3,31188,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31188,1,3,0)
 ;;=3^Pustulosis Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,31188,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,31188,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,31189,0)
 ;;=L40.2^^190^1932^11
 ;;^UTILITY(U,$J,358.3,31189,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31189,1,3,0)
 ;;=3^Acrodermatitis Continua
 ;;^UTILITY(U,$J,358.3,31189,1,4,0)
 ;;=4^L40.2
 ;;^UTILITY(U,$J,358.3,31189,2)
 ;;=^5009162
 ;;^UTILITY(U,$J,358.3,31190,0)
 ;;=L40.3^^190^1932^256
 ;;^UTILITY(U,$J,358.3,31190,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31190,1,3,0)
 ;;=3^Pustulosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,31190,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,31190,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,31191,0)
 ;;=L40.4^^190^1932^157
 ;;^UTILITY(U,$J,358.3,31191,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31191,1,3,0)
 ;;=3^Guttate Psoriasis
 ;;^UTILITY(U,$J,358.3,31191,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,31191,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,31192,0)
 ;;=L40.8^^190^1932^253
 ;;^UTILITY(U,$J,358.3,31192,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31192,1,3,0)
 ;;=3^Psoriasis NEC
